EUVIMEDEUVIMED entdecken
Crossref

SALTO TALARIS Total Ankle Arthroplasty at a Minimum of 10 Years of Follow-up

Maxime Sadoun iD, Fabrice Gaudot iD, Thomas Bauer iD, Yves Stiglitz iD

Journal of Bone and Joint Surgery · 18.06.2026

DOI: 10.2106/jbjs.25.01483 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bone and Joint Surgery, online erschienen am 18.06.2026. Verfasst von Maxime Sadoun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Orthopaedics Department, Raymond Poincaré University Hospital, Paris-Saclay University, Garches, France. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Total ankle arthroplasty (TAA) is increasingly performed worldwide for the treatment of end-stage tibiotalar osteoarthritis. There are limited data in the literature regarding the long-term survival of third-generation implants. The primary aim of this study was to characterize the long-term survival of the SALTO TALARIS TAA implant.

Methods

This was a multisurgeon, single-center, retrospective study of 164 consecutive ankles (155 patients) that underwent surgery between 2009 and 2013. The mean age at surgery was 64.4 years, and 60% of patients were women. The mean follow-up was 12 years (range, 10 to 15 years). Implant survival was estimated using the Kaplan-Meier method. Data collected included implant survival, clinical range of motion, American Orthopaedic Foot & Ankle Society (AOFAS) score, and the number of patients with a “forgotten” joint. The same surgical technique and identical pre- and postoperative radiographic assessments were used for all patients.

Results

One hundred and fifty-five patients with 164 TAAs were initially included; 17 patients (17 TAAs) died, and 3 patients (3 TAAs, 1.8%) were lost to follow-up before 10 years. Survival free from any surgery involving the tibiotalar joint was 94.1% (95% confidence interval [CI]: 90.5% to 97.9%) at 10 years. Implant survival with the end point of revision of at least 1 metallic component was 96.2% (95% CI: 93.4% to 99.2%) at 10 years. Implant survival with the end point of removal and conversion to arthrodesis was 99% (95% CI: 98% to 100%) at 10 years. At the latest follow-up, the mean dorsiflexion (and standard deviation) was 12° ± 5°, the mean plantar flexion was 23° ± 7°, and the median AOFAS score was 98. Patients considered 62 (43%) of the ankles “forgotten” joints.

Conclusions

The SALTO TALARIS TAA is a reliable implant with a low reoperation rate and excellent long-term survival. These findings provide long-term reference survival data for a third-generation fixed-bearing TAA system. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.

Autor:innen und Institutionen

  • Orthopaedics Department, Raymond Poincaré University Hospital, Paris-Saclay University, Garches, France.
  • Clinique Jouvenet, Paris, France.
  • Clinique Victor Hugo, Paris, France.

ORCID-Profile: Maxime Sadoun, Fabrice Gaudot, Thomas Bauer, Yves Stiglitz

Zitieren

APA

Sadoun, M., Gaudot, F., Bauer, T., & Stiglitz, Y. (2026). SALTO TALARIS Total Ankle Arthroplasty at a Minimum of 10 Years of Follow-up. Journal of Bone and Joint Surgery. https://doi.org/10.2106/jbjs.25.01483

Vancouver

Sadoun M, Gaudot F, Bauer T, Stiglitz Y. SALTO TALARIS Total Ankle Arthroplasty at a Minimum of 10 Years of Follow-up. Journal of Bone and Joint Surgery. 2026. doi:10.2106/jbjs.25.01483

BibTeX
@article{Sadoun2026,
  author = {Sadoun, Maxime and Gaudot, Fabrice and Bauer, Thomas and Stiglitz, Yves},
  title = {SALTO TALARIS Total Ankle Arthroplasty at a Minimum of 10 Years of Follow-up},
  journal = {Journal of Bone and Joint Surgery},
  year = {2026},
  doi = {10.2106/jbjs.25.01483}
}
Kostenlos starten →